GS-4997, an Inhibitor of Apoptosis Signal-Regulating Kinase (ASK1), Alone or in Combination with Simtuzumab for the Treatment of Nonalcoholic Steatohepatitis (NASH): A Randomized, Phase 2 Trial

Press/Media: Press / Media

PeriodNov 22 2016

Media coverage

1

Media coverage

  • TitleGS-4997, an Inhibitor of Apoptosis Signal-Regulating Kinase (ASK1), Alone or in Combination with Simtuzumab for the Treatment of Nonalcoholic Steatohepatitis (NASH): A Randomized, Phase 2 Trial
    Media name/outletNational AIDS Treatment Advocacy Project
    CountryUnited States
    Date11/22/16
    PersonsEric J Lawitz